← All trials
NCT03837353
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 30, 2019
- Primary completion
- Mar 31, 2021
- Completion date
- Mar 31, 2021
- First posted
- —
- Last posted
- —
- Enrollment
- 97
- Arms / groups
- 5 / —
- Source
- AACT · ingestion pipeline
Sponsors
- New York UniversityLead sponsor
- Leap Therapeutics, Inc.Collaborator
- New York UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.